Ghalwash, M. ; Anand, V. ; Hagopian, W. ; Lundgren, M. ; Rewers, M. ; Veijola, R. ; Ziegler, A.-G. ; Dunne, J.
Optimal ages for screening for type 1 diabetes risk in children.Gallegos, P.A. ; Balcacean, D. ; Zapardiel-Gonzalo, J. ; Richardson, S. ; Akhbari, P. ; Morgan, N. ; Nelson, G. ; Gerling, I. ; Kusmartseva, I. ; Pugliese, A. ; Rodriguez-Calvo, T.
Presence of markers associated with viral infections in the pancreas before and after onset of type 1 diabetes.Bovy, N. ; Boitard, C. ; Achenbach, P. ; Leslie, R.D. ; Dayan, C. ; Keymeulen, B. ; Owen, K.R. ; Carlier, V. ; Van Mechelen, M. ; Van Rampelbergh, J.
Long-term follow-up study of type 1 diabetes patients previously treated with IMCY-0098 or placebo in young adults with recent-onset type 1 diabetes.Anand, V. ; Achenbach, P. ; Dunne, J.L. ; Hagopian, W. ; Kwon, B. ; Lundgren, M. ; Veijola, R. ; Frohnert, B.I.
Visualising heterogeneous islet autoantibody trajectories of children who develope type 1 diabetes from multi-site birth cohort studies.Kwon, B. ; Achenbach, P. ; Anand, V. ; Dunne, J.L. ; Hagopian, W. ; Lundgren, M. ; Veijola, R. ; Frohnert, B.I.
A visual analytics method to explore the evolution of autoantibodies during progression to type 1 diabetes in multi-site birth cohort studies.Achenbach, P. ; Anand, V. ; Dunne, J.L. ; Hagopian, W. ; Kwon, B. ; Lundgren, M. ; Veijola, R. ; Frohnert, B.I.
Heterogeneous islet autoantibody evolution trajectories in multi-site birth cohort studies.Ott, R. ; Pawlow, X. ; Weiss, A. ; Hofelich, A. ; Herbst, M. ; Hummel, N. ; Prehn, C. ; Adamski, J. ; Römisch-Margl, W. ; Kastenmüller, G. ; Ziegler, A.-G. ; Hummel, S.
Intergenerational metabolomic analysis of mothers with a history of gestational diabetes mellitus and their offspring.Hollstein, T. ; Schulte, D.M. ; Schulz, J. ; Glück, A. ; Ziegler, A.-G. ; Bonifacio, E. ; Wendorff, M. ; Franke, A. ; Schreiber, S. ; Bornstein, S.R. ; Laudes, M.
Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: A case report.Schäfer-Graf, U. ; Laubner, K. ; Hummel, S. ; Gembruch, U. ; Groten, T. ; Kainer, F. ; Grieshop, M. ; Bancher-Todesca, D. ; Cervar-Zivakovic, M. ; Hösli, I. ; Kaltheuner, M. ; Gellner, R. ; Kautzky-Willer, A. ; Bührer, C. ; Patchev, V. ; Nothacker, M.
Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge – Praxisempfehlung – Kurzfassung der S3-Leitlinie (AWMF-Registernummer: 057-008).Bender, C. ; Rodriguez-Calvo, T. ; Amirian, N. ; Coppieters, K.T. ; Von Herrath, M.G.
The healthy exocrine pancreas contains preproinsulin-specific CD8 T cells that attack islets in type 1 diabetes.Casas, R. ; Dietrich, F. ; Barcenilla, H. ; Tavira, B. ; Wahlberg, J. ; Achenbach, P. ; Ludvigsson, J.
Glutamic acid decarboxylase injection into lymph nodes: Beta cell function and immune responses in recent onset type 1 diabetes patients.Rajewsky, N. ; Almouzni, G. ; Gorski, S.A. ; Aerts, S. ; Amit, I. ; Bertero, M.G. ; Bock, C. ; Bredenoord, A.L. ; Cavalli, G. ; Chiocca, S. ; Clevers, H. ; de Strooper, B. ; Eggert, A. ; Ellenberg, J. ; Fernández, X.M. ; Figlerowicz, M. ; Gasser, S.M. ; Hubner, N. ; Kjems, J. ; Knoblich, J.A. ; Krabbe, G. ; Lichter, P. ; Linnarsson, S. ; Marine, J.C. ; Marioni, J. ; Marti-Renom, M.A. ; Netea, M.G. ; Nickel, D. ; Nollmann, M. ; Novak, H.R. ; Parkinson, H. ; Piccolo, S. ; Pinheiro, I. ; Pombo, A. ; Popp, C. ; Reik, W. ; Roman-Roman, S. ; Rosenstiel, P. ; Schultze, J.L. ; Stegle, O. ; Tanay, A. ; Testa, G. ; Thanos, D. ; Theis, F.J. ; Torres-Padilla, M.E. ; Valencia, A. ; Vallot, C. ; van Oudenaarden, A. ; Vidal, M. ; Voet, T. ; LifeTime Community (Schiller, H. B.) ; LifeTime Community (Ziegler, A.-G.)
LifeTime and improving European healthcare through cell-based interceptive medicine.Marcus, B.A. ; Achenbach, P. ; Ziegler, A.-G.
Typ-1-Diabetes: Früherkennung und Ansätze zur Prävention.Update 2020.Ferrat, L.A. ; Vehik, K. ; Sharp, S.A. ; Lernmark, Å. ; Rewers, M.J. ; She, J.X. ; Germany clinical center (Ziegler, A.-G.) ; Toppari, J. ; Akolkar, B. ; Krischer, J.P. ; Weedon, M.N. ; Oram, R.A. ; Hagopian, W.A. ; German Clinical Center (Gezginci, C.) ; German Clinical Center (Hummel, S.) ; German Clinical Center (Knopff, A.) ; German Clinical Center (Scholz, M.) ; German Clinical Center (Stock, J.) ; German Clinical Center (Warncke, K.) ; German Clinical Center (Wendel, L.) ; German Climical Center (Winkler, C.)
A combined risk score enhances prediction of type 1 diabetes among susceptible children.Vehik, K. ; Bonifacio, E. ; Lernmark, A. ; Yu, L. ; Williams, A. ; Schatz, D. ; Rewers, M. ; She, J.X. ; Toppari, J. ; Hagopian, W. ; Akolkar, B. ; Ziegler, A.-G. ; Krischer, J.P.
Hierarchical order of distinct autoantibody spreading and progression to type 1 diabetes in the Teddy study.Ziegler, A.-G. ; Bonifacio, E.
Why is the presence of autoantibodies against GAD associated with a relatively slow progression to clinical diabetes?Schaefer-Graf, U. ; Laubner, K. ; Hummel, S. ; Gembruch, U. ; Groten, T. ; Kainer, F. ; Grieshop, M. ; Bancher-Todesca, D. ; Cervar-Zivakovic, M. ; Hoesli, I. ; Kaltheuner, M. ; Gellner, R. ; Kautzky-Willer, A. ; Buehrer, C. ; Patchev, V. ; Nothacker, M.
Gestational diabetes mellitus (GDM), diagnostics, therapy and aftercare: Practice Recommendation—Abstract of the S3 Guideline (AWMF Register Number: 057-008).Monti, P. ; Vignali, D. ; Ziegler, A.-G. ; Bonifacio, E.
Soluble IL-7 receptor alpha concentration in cord blood is linked to sex and maternal diabetes, but not with subsequent development of type 1 diabetes.Pozzilli, P. ; Bosi, E. ; Cirkel, D. ; Harris, J. ; Leech, N. ; Tinahones, F.J. ; Vantyghem, M.C. ; Vlasakakis, G. ; Ziegler, A.-G. ; Janmohamed, S.
Randomized 52-week phase 2 trial of albiglutide vs placebo in adult patients with newly diagnosed type 1 diabetes.Ziegler, A.-G. ; Kick, K. ; Bonifacio, E. ; Haupt, F. ; Hippich, M. ; Dunstheimer, D. ; Lang, M. ; Laub, O. ; Warncke, K. ; Lange, K. ; Assfalg, R. ; Jolink, M. ; Winkler, C. ; Achenbach, P.
Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany.Li, Q. ; Parikh, H. ; Butterworth, M.D. ; Lernmark, Å. ; Hagopian, W. ; Rewers, M. ; She, J.-X. ; Toppari, J. ; Ziegler, A.-G. ; Akolkar, B. ; Fiehn, O. ; Fan, S. ; Krischer, J.P. ; Teddy Study Group
Longitudinal metabolome-wide signals prior to the appearance of a first islet autoantibody in children participating in the TEDDY Study.Liu, X. ; Vehik, K. ; Huang, Y. ; Larsson, H.E. ; Toppari, J. ; Ziegler, A.-G. ; She, J.-X. ; Rewers, M. ; Hagopian, W.A. ; Akolkar, B. ; Krischer, J.P. ; Teddy Study Group
Distinct growth phases in early life associated with the risk of type 1 diabetes: The TEDDY study.Knoop, J. ; Eugster, A. ; Gavrisan, A. ; Lickert, R. ; Sedlmeier, E.-M. ; Dietz, S. ; Lindner, A. ; Warncke, K. ; Hummel, N. ; Ziegler, A.-G. ; Bonifacio, E.
Maternal type 1 diabetes reduces autoantigen-responsive CD4(+) T cells in Offspring.Sabouri, S. ; Benkahla, M.A. ; Kiosses, W.B. ; Rodriguez-Calvo, T. ; Zapardiel-Gonzalo, J. ; Castillo, E. ; Von Herrath, M.G.
Human herpesvirus-6 is present at higher levels in the pancreatic tissues of donors with type 1 diabetes.Mattila, M. ; Erlund, I. ; Lee, H.S. ; Niinistö, S. ; Uusitalo, U. ; Andrén Aronsson, C. ; Hummel, S. ; Parikh, H. ; Rich, S.S. ; Hagopian, W. ; Toppari, J. ; Lernmark, Å. ; Ziegler, A.-G. ; Rewers, M. ; Krischer, J.P. ; Norris, J.M. ; Virtanen, S.M.
Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: The TEDDY study.Hörber, S. ; Achenbach, P. ; Schleicher, E. ; Peter, A.
Harmonization of immunoassays for biomarkers in diabetes mellitus.